Sunshine Biopharma Inc. (SBFMW) SEC Filings — 2024
33 SEC filings for Sunshine Biopharma Inc. (SBFMW) in 2024.
Filings
- Sunshine Biopharma Files 8-K on Shareholder Matters — 8-K · Dec 10, 2024
- Sunshine Biopharma Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Sunshine Biopharma Files 8-K on Financials — 8-K · Nov 7, 2024
- Sunshine Biopharma Files Q3 2024 10-Q — 10-Q · Nov 5, 2024
- Sunshine Biopharma Files 8-K on Governance Changes — 8-K · Oct 23, 2024
- Sunshine Biopharma Files Definitive Proxy Statement — DEF 14A · Oct 17, 2024
- Sunshine Biopharma Files 8-K — 8-K · Sep 10, 2024
- Sunshine Biopharma Files Amended 10-Q for Q2 2024 — 10-Q/A · Aug 20, 2024
- Sunshine Biopharma Files 8-K on Financials — 8-K · Aug 19, 2024
- Sunshine Biopharma Files Q2 2024 10-Q — 10-Q · Aug 16, 2024
- Sunshine Biopharma Files 8-K on Corporate Changes — 8-K · Aug 12, 2024
- Sunshine Biopharma Files 8-K on Shareholder Vote Matters — 8-K · Jul 2, 2024
- Sunshine Biopharma Files 8-K for Other Events — 8-K · Jul 1, 2024
- Sunshine Biopharma Files 8-K Report — 8-K · Jun 11, 2024
- Sunshine Biopharma Faces Delisting Concerns — 8-K · Jun 7, 2024
- Sunshine Biopharma Files 8-K on Financials — 8-K · May 22, 2024
- Sunshine Biopharma Files Q1 2024 10-Q — 10-Q · May 20, 2024
- Sunshine Biopharma Changes Certifying Accountant — 8-K · May 8, 2024
- Sunshine Biopharma Files 8-K: Accountant Change & Exhibits — 8-K · May 6, 2024
- Sunshine Biopharma Files 8-K on Corporate Amendments — 8-K · Apr 23, 2024
- Sunshine Biopharma Files 8-K on Financials — 8-K · Apr 1, 2024
- Sunshine Biopharma, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 28, 2024
- Sunshine Biopharma Files 8-K: Material Agreement, Equity Sales — 8-K · Mar 6, 2024
- Sunshine Biopharma Faces Delisting Notice — 8-K · Mar 1, 2024
- Sunshine Biopharma, Inc SC 13G Filing — SC 13G · Feb 23, 2024
- Sunshine Biopharma, Inc SC 13G Filing — SC 13G · Feb 21, 2024
- Sunshine Biopharma Files 8-K on Security Holder Vote — 8-K · Feb 16, 2024
- Sunshine Biopharma Enters Material Definitive Agreement — 8-K · Feb 15, 2024
- Sunshine Biopharma, Inc SC 13G Filing — SC 13G · Feb 14, 2024
- Sunshine Biopharma Enters Material Definitive Agreement — 8-K · Feb 12, 2024
- Sunshine Biopharma, Inc. Files S-1/A Amendment — S-1/A · Feb 9, 2024
- Sunshine Biopharma Files S-1 Registration Statement — S-1 · Feb 1, 2024
- Sunshine Biopharma Reports Officer/Director Changes, Compensation on Jan 25 — 8-K · Jan 30, 2024